Feb 20, 2018 Roth Capital Partners Acts as Sole Placement Agent for Delcath Systems, Inc. (DCTH) in its $5 Million Follow-On Roth Capital Partners
Feb 16, 2018 Roth Capital Partners Acts as Sole Placement Agent for My Size, Inc. (NASDAQ: MYSZ; TASE: MYSZ) Offerings with Gross Proceeds Totaling $9.7 Million Roth Capital Partners
Feb 15, 2018 Roth Capital Partners Acts as Financial Advisor for Avid Bioservices (CDMO) Roth Capital Partners
Feb 13, 2018 Roth Capital Partners Acts as Lead Manager for Gemphire Therapeutics Inc. (NASDAQ:GEMP) in its $22 Million Follow-On Roth Capital Partners
Feb 7, 2018 Roth Capital Partners Acts as Co-Manager for Viking Therapeutics, Inc. (VKTX) in its $63.3 Million Follow-On Roth Capital Partners
Feb 6, 2018 Roth Capital Partners Acts as Co-Manager for CymaBay Therapeutics, Inc. (Nasdaq:CBAY) in its $144 Million Follow-On Roth Capital Partners
Feb 2, 2018 Roth Capital Partners Acts as Lead Placement Agent for Q BioMed Inc. (OTCQB: QBIO) in its $5.5 Million Follow-On Roth Capital Partners
Feb 1, 2018 Roth Capital Partners Acts as Financial Advisor to GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris: GTBP.PA) in its $7.1 Million Private Placement Roth Capital Partners
Jan 31, 2018 Roth Capital Partners Acts as Co-Manager for Albireo Pharma, Inc. (ALBO) in its $74.7 Million Follow-On Roth Capital Partners
Jan 30, 2018 Roth Capital Partners Acts as Joint Book-Running Manager for Eyenovia Inc. (EYEN) in its $27.3 Million IPO Roth Capital Partners
